首页|商陆提取物药理作用研究进展

商陆提取物药理作用研究进展

扫码查看
原文链接
  • 万方数据
  • 维普
商陆是我国传统峻下逐水中药,收载于历版《中华人民共和国药典》,入药部位为根部,具有利尿泻下、抗炎、抗肿瘤、祛痰镇咳平喘等药理活性.临床多用于治疗肾炎、肝硬化腹水、乳腺增生、银屑病等疾病.通过对商陆提取物和化学成分药理作用进行总结,为今后商陆深入研究及合理开发利用提供支持和参考依据.
Research Progress in Pharmacological Action of Phytolacca Acinosa Extract
Phytolacca acinosa is a traditional Chinese medicine for expelling water by purgation,which is recorded in the Pharma-copoeia of the People's Republic of China.The medicinal part of Phytolacca acinosa is the root,which has pharmacological activities such as diuresis and purgation,anti-inflammatory,anti-tumor,dispelling phlegm,and relieving cough and asthma.Phytolacca acinosa is mainly used to treat nephritis,cirrhosis ascites,hyperplasia of mammary gland,psoriasis and other diseases.This paper summari-zes the pharmacological effects of phytolacca acinosa extract and its chemical components.It provides support and reference for fur-ther research and rational development and utilization of Phytolacca acinosa in the future.

Phytolacca acinosaPharmacological actionTriterpenoid saponinPolysaccharideAnti-inflammatoryOxidative stressSignaling pathwayMitogen-activated protein kinase

徐静、李晓亮、高宁、王宇、匡海学、梁华

展开 >

黑龙江中医药大学,哈尔滨,150040

黑龙江中医药大学附属第一医院,哈尔滨,150040

海南医学院,海口,571199

商陆 药理作用 三萜皂苷 多糖 抗炎 氧化应激 信号通路 促分裂原活化的蛋白激酶

国家重点基础研究发展计划(973计划)国家自然科学基金黑龙江省中医药经典普及化专项黑龙江省自然科学基金黑龙江中医药大学科研项目

2013CB53180181473563ZYW2023-003JJ2022LH10482018jkcy06

2024

10.3969/j.issn.1673-7202.2024.02.023

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子：1.266
ISSN：1673-7202
年,卷(期)：2024.19(2)
  • 61